NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/30/2026
Back to search
Official data from USPTO
ANMI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
07/30/2026
Trademark type
Word
Nice classes
5, 10, 42
Filing date
08/26/2020
Registration date
06/01/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/01/2021
Last transaction
07/30/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
AU
Examiner
FOSS, KATHERINE M
Law office
N70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Telix Pharmaceuticals Limited
Representatives
Andrew S. Ehard Merchant & Gould P.C.
Technical classification
Nice Classes
Class 5Class 10Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Chemical preparations for pharmaceutical purposesdiagnostic radiopharmaceutical preparations; pharmaceutical preparations for the imagingdiagnosing and monitoring of cancer; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical imaging and detection agents for use in the imagingdiagnosing and monitoring of cancer
Class 10
Medical apparatusinfusion and injection devices sold empty for administering drugs and diagnostic radiopharmaceuticalssyringes; apparatus for medical purposesdrug delivery devices sold empty for diagnostic radiopharmaceuticalssyringes; medical devices for treating cancer; diagnostic imaging apparatus for medical use
Class 42
Scientific research; scientific research in the field of pharmacy; research on the subject of pharmaceuticals; medical research; research and development of products; providing scientific advisory services relating to immunological products; provision of scientific information in the fields of biochemistrybiotechnology and clinical trials; scientific consultancyconsulting services in the fields of biotechnologypharmaceutical research and developmentgenetic science all of the aforementioned in relation to radiopharmaceuticals and cancer
Publications
History of USPTO decisions and trademark events.
29 publications found
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
06/01/2026
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/26/2026
NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/14/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/25/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/23/2021
FIMP
FINAL DISPOSITION PROCESSED
09/23/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/01/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
06/01/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/16/2021
PUBO
PUBLISHED FOR OPPOSITION
03/16/2021
GPNX
NOTIFICATION PROCESSED BY IB
03/15/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/24/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/24/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/24/2021
RFNT
REFUSAL PROCESSED BY IB
02/14/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/09/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/09/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/09/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/09/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/25/2021
RFRR
REFUSAL PROCESSED BY MPU
01/25/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/05/2021
MAFR
APPLICATION FILING RECEIPT MAILED
01/05/2021
CNRT
NON-FINAL ACTION WRITTEN
01/04/2021
DOCK
ASSIGNED TO EXAMINER
12/30/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/30/2020
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
12/28/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/05/2020
Continuous trademark protection
Get notified about every new filing that threatens ANMI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.